Clinical Diagnostics

The eighth edition of this report provides an overview of the life sciences research tools (LSRT) market from 2019 to 2029. LSRT companies offer instruments, reagents and services to academic, biopharma, applied market, and (non-IVD) clinical customers. While the LSRT space includes hundreds of companies, the market is relatively consolidated, with top vendors including Agilent, Becton Dickinson, Danaher, Illumina, Merck-EMD Millipore, and (most notably) Thermo Fisher representing the majority of sales; however, mid-size players (e.g., PacBio) and smaller emerging players (e.g., Element, Quantum-Si) are often growing more rapidly, and driving innovation.

DeciBio conducted 16 interviews with U.S. biopharma and CDMO stakeholders to understand key trends in the development and manufacturing of oligo therapeutics today.

This report provides a summary of the current spatial biology market landscape, as well as a forward-looking perspective of the spatial biology market from 2025 to 2030.

DeciBio conducted 11 interviews with academic researchers and biopharma executives to explore how advanced and next-generation proteomics tools have been adopted into research efforts today and how stakeholders expect their use of these tools to change in 2025